干扰素联合甘露聚糖肽治疗慢性乙型肝炎疗效观察

Curative effect of IFN combined mannatide on chronic hepatitis B

用干扰素联合甘露聚糖肽治疗慢性乙型肝炎70例,1周后白细胞下降率治疗组明显低于对照组.6个月后HbeAg和HBV-DNA阴转率明显高于对照组,疗效较单用干扰素明显提高。

Seventy cases of chronic hepatitis B were treated with IFN combined mannantide. After one week, the WBC decline rate in the treatment group was obviously lower than that of control group. After six months, HbeAg and HBV- DNA conversion negative rates were obviously higher than that of control group, and the curative effects were obviously improved, compared with IFN used only group.